WNT2: A Potential Drug Target and Biomarker (G7472)

Target Name: WNT2

NCBI ID: G7472

WNT2

WNT2: A Potential Drug Target and Biomarker

WNT2, a protein that belongs to the Wnt family of proteins, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The Wnt family of proteins plays a crucial role in the development and maintenance of tissues and organs during embryonic development. During this critical period, the Wnt proteins help to guide the formation of complex structures and tissues that will eventually give rise to the diverse array of organisms that exist today.

WNT2 is a member of the Wnt family that has been implicated in various developmental processes, including tooth and nail growth, tail fin formation, and the development of the nervous system. It is also involved in the regulation of cell proliferation and differentiation, as well as in the formation of the nervous system during embryonic development.

Recent studies have suggested that WNT2 may have potential as a drug target or biomarker for a variety of diseases. For example, WNT2 has been shown to be highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting WNT2 may be an effective way to treat these diseases.

In addition to its potential as a cancer drug target, WNT2 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to contribute to the degenerative changes that occur in these conditions.

WNT2 has also been implicated in the development of developmental disorders, such as Down syndrome and Fragile X syndrome. These conditions are characterized by the presence of genetic mutations that result in the abnormal development or functioning of various tissues and organs.

In conclusion, WNT2 is a protein that has been identified as a potential drug target or biomarker for a variety of diseases. Its involvement in the development and maintenance of tissues and organs during embryonic development, as well as its involvement in the regulation of cell proliferation and differentiation, make it an attractive target for drug development. Further research is needed to fully understand the potential of WNT2 as a drug and to determine its utility as a biomarker for various diseases.

Protein Name: Wnt Family Member 2

Functions: Ligand for members of the frizzled family of seven transmembrane receptors. Functions in the canonical Wnt signaling pathway that results in activation of transcription factors of the TCF/LEF family (PubMed:20018874). Functions as upstream regulator of FGF10 expression. Plays an important role in embryonic lung development. May contribute to embryonic brain development by regulating the proliferation of dopaminergic precursors and neurons (By similarity)

The "WNT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WNT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets